Тreatment of severe psoriasis with secukinumab

Posted on септември 23, 2025

Secukinumab, an IL-17A inhibitor, has been widely used for the treatment of moderate-to-severe plaque psoriasis.This summary presents real-world clinical practice data on the effectiveness and safety of secukinumab in 27patients with psoriasis. Continue Reading